Rosella Locci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Rosella Locci has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Carine Munaut
Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Belgium
1 shared publication - Jean-Michel Foidart
Laboratory of Tumor and Development Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA-R), Université de Liège, Tour de Pathologie (B23) Sart-Tilman, B-4000, Liège, Belgium.
1 shared publication - Michelle Nisolle
Department of Obstetrics and Gynecology, CHR Citadelle Hospital, University of Liège, Liège, Belgium
1 shared publication - Stefano Angioni
Division of Gynecology and Obstetrics, Department of Surgical Sciences University of Cagliari Cagliari Italy
1 shared publication
Latest Publications
- Open Access
- 26 September 2013
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 11 (1) , 94
Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis
Background: Endometrial cells, which are shed by retrograde menstruation, may aberrantly express molecules involved in invasion and migration, leading to endometriosis. The aim of this study was to investigate the expression of the laminin gamma 2 chain (LAMC2) in the tissues of women with and without endometriosis. Methods: Endometrial biopsy specimens were collected from healthy volunteers and from endometriosis patients. Biopsy specimens from the corresponding endometriotic lesions were also collected. The expression of laminin gamma 2 chain was evaluated by immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR). Results: Endometrial tissue from women with or without endometriosis showed constitutive expression of LAMC2 mRNA throughout the menstrual cycle. A higher mRNA level was observed in ectopic endometrium (Ec) from women with endometriosis compared with eutopic endometrium (Eu) from women with endometriosis. Immunohistochemistry revealed a varied pattern of laminin gamma 2 chain expression, with increased epithelial expression in eutopic endometrium from women with endometriosis compared with those without endometriosis. Conclusions: The altered expression of laminin gamma 2 chain in eutopic endometrium from women with endometriosis may provide new opportunities for diagnosis and treatment.
- 26 September 2013
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 11 (1) , 94
Open AccessExpression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis
Background: Endometrial cells, which are shed by retrograde menstruation, may aberrantly express molecules involved in invasion and migration, leading to endometriosis. The aim of this study was to investigate the expression of the laminin gamma 2 chain (LAMC2) in the tissues of women with and without endometriosis. Methods: Endometrial biopsy specimens were collected from healthy volunteers and from endometriosis patients. Biopsy specimens from the corresponding endometriotic lesions were also collected. The expression of laminin gamma 2 chain was evaluated by immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR). Results: Endometrial tissue from women with or without endometriosis showed constitutive expression of LAMC2 mRNA throughout the menstrual cycle. A higher mRNA level was observed in ectopic endometrium (Ec) from women with endometriosis compared with eutopic endometrium (Eu) from women with endometriosis. Immunohistochemistry revealed a varied pattern of laminin gamma 2 chain expression, with increased epithelial expression in eutopic endometrium from women with endometriosis compared with those without endometriosis. Conclusions: The altered expression of laminin gamma 2 chain in eutopic endometrium from women with endometriosis may provide new opportunities for diagnosis and treatment.